332 related articles for article (PubMed ID: 35378274)
1. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine.
Gowd V; Ahmad A; Tarique M; Suhail M; Zughaibi TA; Tabrez S; Khan R
Semin Cancer Biol; 2022 Nov; 86(Pt 2):624-644. PubMed ID: 35378274
[TBL] [Abstract][Full Text] [Related]
2. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
3. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial prospects of nano-targeted chemoimmunotherapy.
Da Silva CG; Rueda F; Löwik CW; Ossendorp F; Cruz LJ
Biomaterials; 2016 Mar; 83():308-20. PubMed ID: 26796043
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-like nanomedicine for cancer immunotherapy.
Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
[TBL] [Abstract][Full Text] [Related]
6. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.
Chakraborty K; Tripathi A; Mishra S; Mallick AM; Roy RS
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35638450
[TBL] [Abstract][Full Text] [Related]
7. Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.
Yadav R; Das PP; Sharma S; Sengupta S; Kumar D; Sagar R
Med Oncol; 2023 Nov; 40(12):347. PubMed ID: 37930458
[TBL] [Abstract][Full Text] [Related]
8. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
Li S; Bennett ZT; Sumer BD; Gao J
Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
[TBL] [Abstract][Full Text] [Related]
10. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.
Peng S; Xiao F; Chen M; Gao H
Adv Sci (Weinh); 2022 Jan; 9(1):e2103836. PubMed ID: 34796689
[TBL] [Abstract][Full Text] [Related]
12. Advancement and Applications of Nanotherapy for Cancer Immune Microenvironment.
He JJ; Li QQ; Zhao C; Zhou J; Wu J; Zhang HB; Zhao YQ; Zhang HH; Lei TY; Zhao XY; You Z; Song QB; Xu B
Curr Med Sci; 2023 Aug; 43(4):631-646. PubMed ID: 37558863
[TBL] [Abstract][Full Text] [Related]
13. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.
Lu Y; Wang Y; Miao L; Haynes M; Xiang G; Huang L
Cancer Lett; 2016 Aug; 379(1):32-8. PubMed ID: 27235608
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine in cisplatin-based cancer therapeutics.
Han Y; Wen P; Li J; Kataoka K
J Control Release; 2022 May; 345():709-720. PubMed ID: 35367476
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment.
Gao S; Yang X; Xu J; Qiu N; Zhai G
ACS Nano; 2021 Aug; 15(8):12567-12603. PubMed ID: 34339170
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicines: Redefining traditional medicine.
Lu W; Yao J; Zhu X; Qi Y
Biomed Pharmacother; 2021 Feb; 134():111103. PubMed ID: 33338747
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based cancer immunotherapy: recent trends and future perspectives.
Lakshmanan VK; Jindal S; Packirisamy G; Ojha S; Lian S; Kaushik A; Alzarooni AIMA; Metwally YAF; Thyagarajan SP; Do Jung Y; Chouaib S
Cancer Gene Ther; 2021 Sep; 28(9):911-923. PubMed ID: 33558704
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy and nanomedicine.
Sheng WY; Huang L
Pharm Res; 2011 Feb; 28(2):200-14. PubMed ID: 20821040
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle delivery systems in cancer vaccines.
Krishnamachari Y; Geary SM; Lemke CD; Salem AK
Pharm Res; 2011 Feb; 28(2):215-36. PubMed ID: 20721603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]